A pilot study — the first to evaluate the TDAG8 expression in patients with panic disorder — reveals significantly increased levels in patients with panic disorder, relative to their healthy control subjects. Researchers found an association with TDAG8 and symptom severity, and observed a relationship between TDAG8 and treatment response in patients who had been treated with antidepressants.